EUVIMEDEUVIMED entdecken
Systematische Übersicht

A systematic review of ketamine's anxiolytic potential in rodent behavioral models of anxiety and PTSD

Alena Lemeshova, Kaya A Patel, Alexander J Bloom, Lindsay Golan, Haney Haidari, Aiman Limbada, Cherish Zhao, Jennifer A Honeycutt

Pharmacology Biochemistry and Behavior · 2026

DOI: 10.1016/j.pbb.2025.174144 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026. Verfasst von Alena Lemeshova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research in Affective and Translational Neuroscience Laboratory, Department of Psychology & Program in Neuroscience, Bowdoin College, Brunswick, ME, …. Hauptthemen laut MEDLINE: Ketamine, Anti-Anxiety Agents, Stress Disorders, Post-Traumatic, Anxiety. Die Arbeit nennt 131 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ketamine, a nonselective NMDA-receptor antagonist, is an emerging therapeutic for treatment-resistant depression and could also be a promising treatment for anxiety and post-traumatic stress disorders. However, preclinical studies in these areas lack methodological standardization, limiting clinical translatability. This review evaluates ketamine's anxiolytic potential in rodents by examining outcomes among different animal models, dosages, and treatment timing. METHODS & RESULTS: A PubMed search of studies published up to July 21, 2025, identified 562 articles assessing ketamine's effects on anxiety and PTSD in rodent models. After applying inclusion and exclusion criteria, 35 studies were analyzed. Key methodological variables, model type, dosage, and timing were summarized to assess consistency and effectiveness across studies. CONCLUSION: Current research on ketamine's anxiolytic potential in rodents is limited by inconsistent methods and inadequate sex inclusion. Evidence suggests that administering 10 to 30 mg/kg intraperitoneally and waiting ≥24 h before behavioral testing procedures produces anxiolytic effects, in deficit models. Future studies should include female subjects and standardized designs to enhance clinical translatability and relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAnti-Anxiety AgentsStress Disorders, Post-TraumaticAnxietyBehavior, AnimalAnimalsDisease Models, AnimalRatsMiceFemaleMale

Substanzen

KetamineAnti-Anxiety Agents

Autor:innen und Institutionen

  • Research in Affective and Translational Neuroscience Laboratory, Department of Psychology & Program in Neuroscience, Bowdoin College, Brunswick, ME, 04011, USA.
  • Research in Affective and Translational Neuroscience Laboratory, Department of Psychology & Program in Neuroscience, Bowdoin College, Brunswick, ME, 04011, USA. Electronic address: jhoneycu@bowdoin.edu.

Zitieren

APA

Lemeshova, A., Patel, K. A., Bloom, A. J., Golan, L., Haidari, H., Limbada, A., Zhao, C., & Honeycutt, J. A. (2026). A systematic review of ketamine's anxiolytic potential in rodent behavioral models of anxiety and PTSD. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2025.174144

Vancouver

Lemeshova A, Patel KA, Bloom AJ, Golan L, Haidari H, Limbada A, et al. A systematic review of ketamine's anxiolytic potential in rodent behavioral models of anxiety and PTSD. Pharmacology Biochemistry and Behavior. 2026. doi:10.1016/j.pbb.2025.174144

BibTeX
@article{Lemeshova2026,
  author = {Lemeshova, Alena and Patel, Kaya A and Bloom, Alexander J and Golan, Lindsay and Haidari, Haney and Limbada, Aiman and Zhao, Cherish and Honeycutt, Jennifer A},
  title = {A systematic review of ketamine's anxiolytic potential in rodent behavioral models of anxiety and PTSD},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2026},
  doi = {10.1016/j.pbb.2025.174144}
}
Kostenlos starten →